title: [Use of antidepressants during pregnancy].
abstract: Pharmacological treatment of depression during pregnancy must balance the potential fetal risks of the medication with the risks of an undertreated or untreated depression. The choice of treatment is difficult and an increasing number of pregnant women and their doctors face the dilemma. There are non-pharmacological options for treatment but they may not be sufficient or available. The paper summarises the potential fetal effects of antidepressant use during pregnancy and attempts to put these effects in a clinical context.
authors.affiliation: Gynækologisk-Obstetrisk Afdeling Y, Klinisk Institut, Aarhus Universitetshospital, Skejby, Denmark.
authors.forename: Lars Henning
authors.initials: LH
authors.lastname: Pedersen
authors.forename: Poul
authors.initials: P
authors.lastname: Videbech
mesh_terms: D000014:Abnormalities, Drug-Induced / Q000209:etiology; D000928:Antidepressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D003863:Depression / Q000188:drug therapy*; D003866:Depressive Disorder / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008431:Maternal-Fetal Exchange; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D012307:Risk Factors; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D000928:Antidepressive Agents; D017367:Selective Serotonin Reuptake Inhibitors